Cardinal Health Q1 Earnings: Margins Signal More Upside
2024-11-04Seeking Alpha
Cardinal Health's Q1 2025 earnings reaffirm my buy rating due to a strengthening pharmacy business and industry tailwinds. Despite initial market overreaction to 2025 guidance, Cardinal Health's management is transparently mitigating risks. A DCF ana undefined
